Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026 and May 2026.
- Largest single sale: $352K (1,575 shares) of Ligand Pharmaceuticals Inc on May 13, 2026. Filing
- Last sale before this period: Oct 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ligand Pharmaceuticals Inc (LGND) | Director | Jan 6, 2004 | Jun 9, 2026 |
| Travere Therapeutics, Inc. (TVTX) | Former Director | Apr 3, 2015 | May 10, 2019 |
Also a director at
Travere Therapeutics, Inc. (TVTX) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 5, 2026, Ligand Pharmaceuticals Inc: 836 shares granted. 1 filing: 1
- May 13, 2026, Ligand Pharmaceuticals Inc: sold 1,575 shares for $352K, under a disclosed plan; 1,575 shares acquired by exercising options. 1 filing: 1
- May 12, 2026, Ligand Pharmaceuticals Inc: sold 459 shares for $103K, under a disclosed plan; 459 shares acquired by exercising options. 1 filing: 1
- May 1, 2026, Ligand Pharmaceuticals Inc: sold 467 shares for $108K, under a disclosed plan. 1 filing: 1
- Apr 1, 2026, Ligand Pharmaceuticals Inc: sold 467 shares for $94K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.